Luis Madera Marin

Internal Medicine physician in Albuquerque, New Mexico — also lists obesity medicine in the CMS registry.

Practice Details

Address
MSC10 5550 1 University Of New Mexico
Albuquerque, NM 87131
Taxonomy
Internal Medicine
Credential
MD
NPPES Enumeration
Listed with NPPES since 2018
Sole Proprietor
Yes
Provider Gender (NPPES)
Male
NPPES Record Updated
February 2026

Specialty taxonomies on file (3)

  • Internal Medicine
  • Internal Medicine
    Internal Medicine, Nephrology
    Primary
  • Endocrinology
    Internal Medicine, Endocrinology, Diabetes & Metabolism

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

Luis Madera Marin is an Internal Medicine physician in Albuquerque whose NPPES record also lists an obesity-medicine or bariatric-medicine taxonomy as a secondary specialty. Primary-care and family-medicine clinicians who carry this secondary designation are among those most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices — call ahead to confirm.

Locally, this is 1 of 664 Internal Medicine practices in Albuquerque carrying this exact taxonomy in our directory.

What to expect at an Internal Medicine visit

Internal-medicine practices manage adult and often complex chronic conditions. A GLP-1-related visit commonly involves:

  • A review of chronic conditions, medications, and cardiovascular/metabolic risk.
  • Baseline labs (A1c, metabolic panel, lipids) to guide treatment.
  • A discussion of GLP-1 options for diabetes and/or weight management.
  • A plan for follow-up monitoring and dose adjustment.

This is general guidance for internal medicine practices, not a description of Luis Madera Marin's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 505-272-4661.

GLP-1 access in Albuquerque, New Mexico

Adult obesity rate
31.7%
#29 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$199/mo
Typical New Mexico telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
New Mexico Medicaid, obesity indication

About 31.7% of New Mexico adults have obesity (BMI 30+), ranking the state #29 of 50 (CDC BRFSS). Our directory currently lists 52 GLP-1-relevant clinics in Albuquerque. If a cash-pay route makes more sense, compounded semaglutide through New Mexico telehealth averages about $199/mo — well below brand-name Wegovy or Zepbound.

Explore more New Mexico options on the best New Mexico GLP-1 providers page, browse every Albuquerque listing in the Albuquerque clinic directory.

Related Practices in Albuquerque

Other Albuquerque listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to New Mexico addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured New Mexico telehealth partners:

Featured Partners · Albuquerque

Featured GLP-1 providers serving Albuquerque

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →

See more Albuquerque options on the Albuquerque clinic directory, our Albuquerque GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Albuquerque obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Luis Madera Marin's specialty taxonomy but not the specific medications it prescribes or its current service menu. Luis Madera Marin is listed under Internal Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 505-272-4661 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Luis Madera Marin's primary specialty on file is Internal Medicine, with obesity medicine listed as a secondary taxonomy. Generalist clinicians who carry that secondary designation are among those who commonly manage GLP-1 prescribing, though the registry does not confirm current services.
Luis Madera Marin is located at MSC10 5550 1 University Of New Mexico, Albuquerque, NM 87131. The phone number listed in the registry is 505-272-4661. Its full record is public in the CMS National Provider registry under NPI 1689166795.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Luis Madera Marin is currently accepting new patients. Call the practice at 505-272-4661 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.